Eisenhower Army Medical Center

Fort Eisenhower, Georgia 30905

2 studies enrolling now · 5 studies all time

What they study most

Breast Adenocarcinoma, Invasive Breast Carcinoma, Malignant Solid Neoplasm, Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma, Recurrent Breast Carcinoma, Recurrent HER2-Positive Breast Carcinoma, Stage III Breast Cancer AJCC v6, Stage III Breast Cancer AJCC v7, Stage III Colon Cancer, Stage IV Breast Cancer AJCC v6 and v7

Studies at this site

• Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease — Recruiting now
• Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors — Recruiting now
• Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer — Running, not enrolling
• Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer — Stopped early
• Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer — Completed